Whilst the majority of the other components of the biomarker panel15 had previously been linked to AD17, 18, 19, 20, 21, it was thought that these studies were the first to implicate Keratin 9 (and also Tetranectin) in AD pathology. This evidence concerns the gene KRT9 and Alzheimer disease.